Drugs in MeSH Category Anti-HIV Agents
✉ Email this page to a colleague
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hetero Labs Ltd Iii | STAVUDINE | stavudine | CAPSULE;ORAL | 078957-001 | Dec 29, 2008 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Natco | LAMIVUDINE | lamivudine | TABLET;ORAL | 204528-001 | Mar 4, 2016 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Apotex | NEVIRAPINE | nevirapine | TABLET, EXTENDED RELEASE;ORAL | 205258-001 | Apr 3, 2014 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Bristol Myers Squibb | VIDEX EC | didanosine | CAPSULE, DELAYED REL PELLETS;ORAL | 021183-002 | Oct 31, 2000 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Bristol Myers Squibb | VIDEX | didanosine | FOR SOLUTION;ORAL | 020155-003 | Oct 9, 1991 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Janssen Prods | EDURANT | rilpivirine hydrochloride | TABLET;ORAL | 202022-001 | May 20, 2011 | RX | Yes | Yes | 7,125,879*PED | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Prinston Inc | NEVIRAPINE | nevirapine | TABLET;ORAL | 078644-001 | May 22, 2012 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
